Stephen Yoo, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 15,000 shares at $18.66 ($280K) on 2017-07-20, disclosed to the SEC on 2017-07-24.
Open-market sale of $280k RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2018-11-07 | $2.5M | — | Filing → |
| RGNX | SELL | 2018-10-31 | $2.3M | — | Filing → |
| RGNX | SELL | 2018-10-17 | $1.9M | — | Filing → |